Final Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOA


Werte in diesem Artikel
Aktien

6.17 EUR -0.03 EUR -0.48 %

LOS ANGELES, March 10, 2025 /PRNewswire/ --  The DJS Law Group reminds investors of a class action lawsuit against BioAge Labs, Inc. ("BioAge" or "the Company") (NASDAQ: BIOA) for violations of the federal securities laws.

DJS Law Group

Shareholders who purchased the Company's securities pursuant and/or traceable to the Company's initial public offering ("IPO") conducted on September 26, 2024, are encouraged to contact the firm before March 10, 2025.

CASE DETAILS:  According to the Complaint, BioAge allegedly made false and misleading statements to the market when it announced on December 6, 2024, that it would discontinue its ongoing STRIDES Phase 2 trial of its lead trial candidate, azelaprag. The Company cited safety concerns in participants as the reason for the discontinuation, contrary to its claims during the IPO that azelaprag had potential in patients in obesity therapy with incretin drugs.

If you are a shareholder who suffered a loss, contact us to participate.

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
 Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/final-deadline-for-the-bioage-labs-inc-securities-lawsuit---contact-the-djs-law-group-to-discuss-your-rights---bioa-302396627.html

SOURCE DJS Law Group LLP

Aktuelle BioAge Labs Aktie News

Werbung

BioAge Labs Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für BioAge Labs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

Keine Analysen gefunden.

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.